News
News

The latest updates from AFAR.

Nathan Shock Centers Coordinating Center to co-host Webinar on Data Integrity on Mon Dec 4

Nov 27
2017

Nathan Shock Centers Coordinating Center to co-host Webinar on Data Integrity on Mon Dec 4

  RECORDING NOW AVAILABLE HERE     As the Nathan Shock Centers Coordinating Center, AFAR and Indiana University School of Public Health-Bloomington will co-host a Webinar: INCORPORATING RIGOR, REPRODUCIBILITY, AND TRANSPARENCY INTO AGING PROJECTS AND PAPERS Monday, December 4, 2017 12:30 pm -1:30 pm EST   Featuring presentations by David B. Allison, PhD and Andrew W. Brown, PhD. Facilitated by Steven N. Austad, PhD.  


View MoreREAD MORE


AFAR and Glenn Foundation announce 2017 BIG Awards

Nov 27
2017

AFAR and Glenn Foundation announce 2017 BIG Awards

AFAR and The Glenn Foundation for Medical Research proudly announce the recipients of the 2017 Glenn Foundation for Medical Research Breakhroughs in Gerontology (BIG) Awards: - Pinchas Cohen, MD, Dean- Davis School of Gerontology at the University of Southern California - William Mair, PhD, Associate Professor, Harvard T.H. Chan School of Public Health Learn more about their awards in related press releases here. Sponsored by The Glenn Foundation for Medical Research, in collaboration with the American Federation for Aging Research (AFAR), the "Breakthroughs in Gerontology (BIG)" initiative provides timely support to a small number of research projects that are relatively…


View MoreREAD MORE


Board Member in the News: Nir Barzilai receives $6.3 mill NIH Alzheimer's grant

Nov 20
2017

Board Member in the News: Nir Barzilai receives $6.3 mill NIH Alzheimer's grant

AFAR Deputy Scientific Director Nir Barzilai, MD and his team at Albert Einstein College of Medicine have received a $6.3 million grant from the National Insitutes of Health (NIH) to identify networks of genes in healthy centenarians that protect them against dementia. The results could help identify new targets for drugs to treat Alzheimer's. Notes Dr. Barzilai: "Aging is the number one risk factor for Alzheimer's, but there are individuals with extraordinary longevity--95 years or older--who have a natural resistance to dementia. We hope to unlock the secrets in their genomes to reveal promising targets for drug…


View MoreREAD MORE


Board Member in the News: Thomas Rando latest research on muscle stem cell in Cell Reports

Nov 20
2017

Board Member in the News: Thomas Rando latest research on muscle stem cell in Cell Reports

On November 14,2017, MedicalXpress reported on research authored by Board Member and two time grantee Thomas Rando, MD, PhD in the November 14 issue of Cell Reports on muscle stem cells. In the article, “Stem cells express genes differently in the lab dish than in the body, study finds”, MedicalXPress notes: The research suggests that any conclusions about stem cell function based on studies of isolated stem cells may now need to be reconsidered in light of the fact that the cells' biology changes during isolation. The results confirmed what previous research in Rando's laboratory has shown: Despite their…


View MoreREAD MORE


AFAR and The Gilbert Foundation announce three, 2017 New Investigator Awards in Alzheimer's Disease

Nov 17
2017

AFAR and The Gilbert Foundation announce three, 2017 New Investigator Awards in Alzheimer's Disease

AFAR and The Rosalinde and Arthur Gilbert Foundation proudly announce the recipients of the 2017 New Investigator Awards in Alzhiemer's Disease: - Congcong He, PhD, Assistant Professor, Northwestern University.  - Arieh Moussaieff, PhD, Senior Lecturer, The Hebrew University of Jerusalem - Hsiao-Ying Wey, PhD, Assistant Professor, Massachusetts General Hospital and Harvard Medical School Learn more about their awards in related press releases here. The New Investigator program is funded by The Rosalinde and Arthur Gilbert Foundation and provides three early-career researchers with up to $100,000 each to conduct scientific investigations leading to improved methods of prevention, diagnosis…


View MoreREAD MORE


AFAR and Arthritis National Research Foundation award 2017 Arthritis and Aging Research Grant

Nov 17
2017

AFAR and Arthritis National Research Foundation award 2017 Arthritis and Aging Research Grant

The collaboratively funded Arthritis and Aging Research Grant has been awarded to Brian Diekman, PhD of the University of North Carolina at Chapel Hill for 2017. Since 2012, AFAR and the Arthritis National Research Foundation (ANRF), the only charity solely focused on funding arthritis research to cure arthritis, have been partners to support arthritis projects that are related to the age-related processes. Through the $100,000 ANRF/AFAR grant, Dr. Diekman--an Assistant Professor at the Joint Department of Biomedical Engineering at the University of North Carolina at Chapel Hill and North Carolina State University--will research cellular senescence as a driver and therapeutic…


View MoreREAD MORE


Grantees in the News: Thomas Robinson and Jeremy Walston on testing frailty before surgery in NY Times

Nov 16
2017

Grantees in the News: Thomas Robinson and Jeremy Walston on testing frailty before surgery in NY Times

  On October 27, 2017, The New York Times spotlighted Beeson Scholars Thomas Robinson, MD (2010) and Jeremy D. Walston, MD (1998) in a feature exploring how surgeons are now assessing older patients frailty to assess likelihood of recooperation and survival from procedures. The article, “One Last Question Before the Operation: Just How Frail Are You?” notes: But about 15 percent of the older population, excluding nursing home residents, meets the criteria for frailty, rising to more than a third of those over age 85. “There’s a much higher prevalence in the Deep South and among African Americans,” said Dr.…


View MoreREAD MORE


Grantees in the News: New York Times article on Supercentenarian DNA sites several AFAR experts

Nov 16
2017

Grantees in the News: New York Times article on Supercentenarian DNA sites several AFAR experts

On November 13, 2017, The New York Times highlighted 1998 Beeson Scholar Thomas T. Perls, MD, MPH, FACP in a feature exploring the role of genetic in the healthspan of “Supercentenarians.” The article, “The Secret to Long Life? It May Lurk in the DNA of the Oldest Among Us”, highlighted Dr. Perl’s research with centerarian DNA and the New England Centenarian Study. The article also links to related research by a range of AFAR experts including: --A study co-authored by Dr. Perls with AFAR Deputy Scientific Director Nir Barzilai, MD in The Journal of Gerontology --A Science…


View MoreREAD MORE


Grantee in the News: Joanne Turner appointed VP for Research at Texas Biomedical Research Institute

Nov 14
2017

Grantee in the News: Joanne Turner appointed VP for Research at Texas Biomedical Research Institute

  AFAR congratulates 2010 Julie Martin Mid-Career Award recipient Joanne Turner, PhD on her recent appointment as Vice President for Research at Texas Biomedical Research Institute. Dr. Turner is a preeminent scientist in tuberculosis (TB) research and the immune system in older patients Read more about Dr. Turner’s research and recent appointment here.  


View MoreREAD MORE


Grantee in the News: Jeremy Walston, MD advances research on gel to treat older patients' skin wounds.

Nov 14
2017

Grantee in the News: Jeremy Walston, MD advances research on gel to treat older patients' skin wounds.

On November 1, 2017, Science Daily reported on research co-authored by 1998 Beeson Scholar Jeremy D. Walston, MD on a gel with potential to heal often untreatable skin wounds common to diabetics and older patients. Dr. Walston co-authored the findings, published originally in the October 16 issue of the Journal of Investigative Dermatology. Through this research, the team seeks approval from the U.S. Food and Drug Administration (FDA) to use the gel application in treatment-resistant skin wounds among diabetics and others, particularly older adults. Read the Science Daily story here. The original research in the Journal of Investigative Dermatology is available by subscription-only,…


View MoreREAD MORE


Board Member in the News: Steve Austad’s latest HuffPo column on Circadian Clocks and Longevity

Nov 02
2017

Board Member in the News: Steve Austad’s latest HuffPo column on Circadian Clocks and Longevity

On November 2, 2017, Huffington Post published the latest column by AFAR Scientific Director Steven N. Austad, PhD exploring research on circadian clocks and longevity. In "Clocks, Flies, and The Nobel Prize," Dr. Austad expands on the recent 2017 Nobel Prize in Physiology or Medicine for research on flies; sleeping patterns or circadian clock by applying this to the relationship between sleep, diet, neurological disease, and longevity. Dr. Austad also notes related research led by AFAR-affiliated experts including: Studies on short-term fasts by Vincent Cristofalo Rising Star Award in Aging Research winners and grantees Valter Longo, PhD and Luigi Fontana, MD, PhD …


View MoreREAD MORE




BACK TO TOPBACK TO TOP